LOW-DOSED ORAL DOSAGE FORM OF AN AKR1C3 INHIBITOR FOR TREATMENT OF DISEASES

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP16178913.6

公开号：

EP3269373A1

申请日:

2016.07.11

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

The present invention relates to a low-dosed oral dosage form for treatment and/or prophylaxis of diseases, especially of endometriosis, polycystic ovary syndrome and atopic dermatitis. More particularly, the present invention concerns oral dosage forms comprising up to 120 mg N-{[17-(5-Fluoropyridin-3-yl)estra-1,3,5(10),16-tetraen-3-yl]carbonyl}-N-methyl-β-alanine per day..

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/